Медицинская библиотека · Anticancer research · 2013

Acute oesophageal toxicity related to paclitaxel-based concurrent chemoradiotherapy for non-small cell lung cancer.

Maráz Anikó, Furák József, Varga Zoltán, Fodor Emese, Együd Zsófia, Borzási Emoke, Kahán Zsuzsanna, Pálföldi Regina, Tiszlavicz László, Hideghéty Katalin

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Dosimetric data and acute oesophageal toxicity (AET) during chemoradiotherapy (CRT) were evaluated in patients with non-small cell lung cancer (NSCLC).

PATIENTS AND

METHODS

Fifty patients were treated with paclitaxel-based conformal CRT with a mean ± SD dose of 60.7 ± 9.8 Gy. The oesophageal toxicity was prospectively registered and evaluated in relation to the maximal dose (Dmax), mean dose (D(mean)), length and volume of oesophagus irradiated with 35-60 Gy (V(35-60Gy)), and according to the seriousness of AET.

RESULTS

Dmax and D(mean) to the oesophagus were 57.0 ± 10.8 Gy and 24.9 ± 9.0 Gy, respectively. AET of grade 1, 2 and 3 developed in 16 (32%), 14 (28%) and three (6%) cases, respectively. The Dmax, D(mean), length and the V(35-60Gy) were all related to dysphagia (p<0.001). V(45Gy) was the most reliable predictor of AET of grade 2 or more.

CONCLUSION

Our results indicate that keeping oesophageal V(45Gy) below 32.5% can prevent severe AET during CRT of NSCLC.

Для цитирования: Maráz Anikó, Furák József, Varga Zoltán, Fodor Emese, Együd Zsófia, Borzási Emoke, Kahán Zsuzsanna, Pálföldi Regina, Tiszlavicz László, Hideghéty Katalin. Acute oesophageal toxicity related to paclitaxel-based concurrent chemoradiotherapy for non-small cell lung cancer.. Anticancer research. 2013.

Предметные рубрики MeSH

Подготовка и перевод публикации

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.